Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma.
[esophageal squamous cell carcinoma]
The
prognostic
value
of
inflammation
indexes
in
esophageal
cancer
was
not
established
.
In
this
study
,
therefore
,
both
prognostic
values
of
Glasgow
prognostic
score
(
GPS
)
and
combination
of
platelet
count
and
neutrophil
lymphocyte
ratio
(
COP-NLR
)
in
patients
with
esophageal
squamous
cell
carcinoma
(
ESCC
)
were
investigated
and
compared
.
This
retrospective
study
included
375
patients
who
underwent
esophagectomy
for
ESCC
.
The
cancer
-
specific
survival
(
CSS
)
was
calculated
by
the
Kaplan-
Meier
method
,
and
the
difference
was
assessed
by
the
log-rank
test
.
The
GPS
was
calculated
as
follows
:
patients
with
elevated
C-
reactive
protein
(
>
Â
10
mg
/
l
)
and
hypoalbuminemia
(
<
Â
35
g
/
l
)
were
assigned
to
GPS
2
.
Patients
with
one
or
no
abnormal
value
were
assigned
to
GPS
1
or
GPS
0
,
respectively
.
The
COP-NLR
was
calculated
as
follows
:
patients
with
elevated
platelet
count
(
>
Â
300
×
10
(
9
)
/
l
)
and
neutrophil
lymphocyte
ratio
(
>
Â
3
)
were
assigned
to
COP-NLR
2
.
Patients
with
one
or
no
abnormal
value
were
assigned
to
COP-NLR
1
or
COP-NLR
0
,
respectively
.
The
5
-
year
CSS
in
patients
with
GPS
0
,
1
,
and
2
was
50
.
0
%
,
27
.
0
%
,
and
12
.
5
%
,
respectively
(
P
<
.
001
)
.
The
5
-
year
CSS
in
patients
with
COP-NLR
0
,
1
,
and
2
was
51
.
8
%
,
27
.
0
%
,
and
11
.
6
%
,
respectively
(
P
<
.
001
)
.
Multivariate
analysis
showed
that
both
GPS
(
P
=
.
003
)
and
COP-NLR
(
P
=
.
003
)
were
significant
predictors
in
such
patients
.
In
addition
,
our
study
demonstrated
a
similar
hazard
ratio
(
HR
)
between
COP-NLR
and
GPS
(
HR
=
1
.
394
vs
HR
=
1
.
367
)
.
COP-NLR
is
an
independent
predictive
factor
in
patients
with
ESCC
.
We
conclude
that
COP-NLR
predicts
survival
in
ESCC
similar
to
GPS
.
Diseases
Validation
Diseases presenting
"specific survival"
symptom
dedifferentiated liposarcoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
liposarcoma
pleomorphic liposarcoma
well-differentiated liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom